1. Multifarious Targets and Recent Developments in the Therapeutics for the Management of Bone Cancer Pain
   Anagha Gadepalli et al, 2021, ACS Chemical Neuroscience CrossRef
2. Recent development in antihyperalgesic effect of phytochemicals: anti-inflammatory and neuro-modulatory actions
   Ajeet Kumar Singh et al, 2018, Inflammation Research CrossRef
3. Astrocytic purinergic signalling contributes to the development and maintenance of neuropathic pain via modulation of glutamate release
   Suting Liu et al, 2023, Journal of Neurochemistry CrossRef
4. The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids
   Rebecca Speltz et al, 2020, Pain CrossRef
5. Mechanisms of cancer pain
   Rayan Haroun et al, 2023, Frontiers in Pain Research CrossRef
6. Electroacupuncture Alleviates Dry Eye Ocular Pain Through TNF-ɑ Mediated ERK1/2/P2X3R Signaling Pathway in SD Rats
   Mi-Mi Wan et al, 2023, Journal of Pain Research CrossRef
7. XPro1595 ameliorates bone cancer pain in rats via inhibiting p38-mediated glial cell activation and neuroinflammation in the spinal dorsal horn
   Kai-Xiang Zhou et al, 2019, Brain Research Bulletin CrossRef
8. Research focus and thematic trends of transient receptor potential vanilloid member 1 research: a bibliometric analysis of the global publications (1990–2023)
   Xin Liu et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
9. Perispinal etanercept advances as a neurotherapeutic
   Edward Tobinick, 2018, Expert Review of Neurotherapeutics CrossRef
10. Butein, a potential drug for the treatment of bone cancer pain through bioinformatic and network pharmacology
    Xin Liu et al, 2023, Toxicology and Applied Pharmacology CrossRef